"Areas of expertise at Wolfe Eye Clinic Des Moines include cataract, glaucoma, oculoplastics, cornea, LASIK and retina surgery including the treatment of macular degeneration and diabetic eye disease. Many of the eye doctors seeing patients in Des Moines are fellowship-trained, meaning they have additional training in their specific field of study. Our eye surgeons and our entire staff look forward to serving your personal eye care needs. The Wolfe Eye Clinic Des Moines office is also home to the Wolfe Surgery Center."

During the past decade, Wolfe Eye Clinic conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 23 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 19 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wolfe Eye Clinic" #1 sponsor was "Jaeb Center for Health Research" with 14 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Genentech, Inc." with 7 trials sponsored, "Gyroscope Therapeutics Limited" with 4 trials sponsored and "Kodiak Sciences Inc" with 4 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wolfe Eye Clinic" #1 collaborator was "National Eye Institute (NEI)" with 13 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Novartis Pharmaceuticals" with 4 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 4 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Wolfe Eye Clinic" are "Diabetic Macular Edema" (11 trials), "Geographic Atrophy" (10 trials), "Dry Age-related Macular Degeneration" (4 trials), "Macular Degeneration" (4 trials) and "Diabetic Retinopathy" (3 trials). Many other conditions were trialed in "Wolfe Eye Clinic" in a lesser frequency.

Most popular intervention types in "Wolfe Eye Clinic" are "Drug" (36 trials), "Other" (15 trials), "Device" (6 trials), "Procedure" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Aflibercept" (6 trials), "Faricimab" (6 trials), "Lampalizumab" (5 trials) and "KSI-301" (4 trials). Other intervention names were less common.

The vast majority of trials in "Wolfe Eye Clinic" are 46 trials for "All" genders.

Currently, there are NaN active trials in "Wolfe Eye Clinic". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Wolfe Eye Clinic, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Wolfe Eye Clinic, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".